<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Musculoskelet Disord</journal-id><journal-id journal-id-type="iso-abbrev">BMC Musculoskelet Disord</journal-id><journal-title-group><journal-title>BMC Musculoskeletal Disorders</journal-title></journal-title-group><issn pub-type="epub">1471-2474</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23987561</article-id><article-id pub-id-type="pmc">3765873</article-id><article-id pub-id-type="publisher-id">1471-2474-14-256</article-id><article-id pub-id-type="doi">10.1186/1471-2474-14-256</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Effects of eye movement desensitization and reprocessing (EMDR) on non-specific chronic back pain: a randomized controlled trial with additional exploration of the underlying mechanisms</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Tesarz</surname><given-names>Jonas</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jonas.tesarz@med.uni-heidelberg.de</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Gerhardt</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>andreas.gerhardt@med.uni-heidelberg.de</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Leisner</surname><given-names>Sabine</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>sabine.leisner@med.uni-heidelberg.de</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Janke</surname><given-names>Susanne</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>susanne.janke@med.uni-heidelberg.de</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Hartmann</surname><given-names>Mechthild</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>mechthild.hartmann@med.uni-heidelberg.de</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Seidler</surname><given-names>G&#x000fc;nther H</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>guenther.seidler@med.uni-heidelberg.de</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Eich</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>wolfgang.eich@med.uni-heidelberg.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Internal Medicine and Psychosomatics, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg D-69120, Germany</aff><aff id="I2"><label>2</label>Department of Internal Medicine and Psychosomatics, University Hospital Heidelberg, Thibautstr. 2, Heidelberg D-69115, Germany</aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>30</day><month>8</month><year>2013</year></pub-date><volume>14</volume><fpage>256</fpage><lpage>256</lpage><history><date date-type="received"><day>23</day><month>7</month><year>2013</year></date><date date-type="accepted"><day>28</day><month>8</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Tesarz et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Tesarz et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2474/14/256"/><abstract><sec><title>Background</title><p>Non-specific chronic back pain (CBP) is often accompanied by psychological trauma, but treatment for this associated condition is often insufficient.</p><p>Nevertheless, despite the common co-occurrence of pain and psychological trauma, a specific trauma-focused approach for treating CBP has been neglected to date. Accordingly, eye movement desensitization and reprocessing (EMDR), originally developed as a treatment approach for posttraumatic stress disorders, is a promising approach for treating CBP in patients who have experienced psychological trauma.</p><p>Thus, the aim of this study is to determine whether a standardized, short-term EMDR intervention added to treatment as usual (TAU) reduces pain intensity in CBP patients with psychological trauma vs. TAU alone.</p></sec><sec><title>Methods/design</title><p>The study will recruit 40 non-specific CBP patients who have experienced psychological trauma. After a baseline assessment, the patients will be randomized to either an intervention group (n&#x02009;=&#x02009;20) or a control group (n&#x02009;=&#x02009;20). Individuals in the EMDR group will receive ten 90-minute sessions of EMDR fortnightly in addition to TAU. The control group will receive TAU alone. The post-treatment assessments will take place two weeks after the last EMDR session and six months later.</p><p>The primary outcome will be the change in the intensity of CBP within the last four weeks (numeric rating scale 0&#x02013;10) from the pre-treatment assessment to the post-treatment assessment two weeks after the completion of treatment.</p><p>In addition, the patients will undergo a thorough assessment of the change in the experience of pain, disability, trauma-associated distress, mental co-morbidities, resilience, and quality of life to explore distinct treatment effects. To explore the mechanisms of action that are involved, changes in pain perception and pain processing (quantitative sensory testing, conditioned pain modulation) will also be assessed.</p><p>The statistical analysis of the primary outcome will be performed on an intention-to-treat basis. The secondary outcomes will be analyzed in an explorative, descriptive manner.</p></sec><sec><title>Discussion</title><p>This study adapts the standard EMDR treatment for traumatized patients to patients with CBP who have experienced psychological trauma. This specific, mechanism-based approach might benefit patients.</p></sec><sec><title>Trial registration</title><p>This trial has been registered with ClinicalTrials.gov (<ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov/ct2/show/NCT01850875">NCT01850875</ext-link>).</p></sec></abstract><kwd-group><kwd>Eye movement desensitization and reprocessing</kwd><kwd>EMDR</kwd><kwd>Non-specific chronic back pain</kwd><kwd>Psychological trauma</kwd><kwd>Randomized controlled trial</kwd><kwd>Study protocol</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Chronic pain conditions of the musculoskeletal system are common and have high socioeconomic relevance [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. This is especially true for pain conditions with widely unknown pathogenesis, such as non-specific chronic back pain (CBP). In addition prevalence as well as the demand for consultation and treatment increases [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>], thus causing high direct and indirect costs [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Despite high prevalence, CBP remains poorly understood and predominantly unspecific and inadequately treated.</p><p>Further, CBP is often complicated by the presence of mental co-morbidities, but treatment for this association remains insufficient. An important comorbidity that has been neglected so far is the role of psychological trauma in the development and maintenance of CBP. Traumatic events have higher prevalence rates in CBP patients as compared to pain-free controls or other diseases [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p><p>Between 10% and 50% of patients receiving tertiary care treatment for chronic pain have symptoms according to psychological trauma and posttraumatic stress disorder [<xref ref-type="bibr" rid="B9">9</xref>]. Moreover, chronic pain is associated with higher exposure to psychological trauma [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. Contrary, only 23.8% of the German population reports a traumatic experience (fulfilling DSM-IV A criteria) and only 2.9% have diagnoses of a posttraumatic stress disorder [<xref ref-type="bibr" rid="B12">12</xref>]. Concerning traumatic experiences it was suggested that multiple traumas have a cumulative effect on physical health, including back pain and that the impact of the trauma on health may be independent of the development of a posttraumatic stress disorder [<xref ref-type="bibr" rid="B13">13</xref>]. This was supported in a prospective study that suggested that in the transition from acute to chronic pain cumulative trauma exposure appeared to be an independent risk factor [<xref ref-type="bibr" rid="B14">14</xref>]. In addition, absence of recent adverse life events independently predicted musculoskeletal health in a prospective study [<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Considering the association of chronic pain and symptoms of posttraumatic stress disorder a model of shared vulnerability and mutual maintenance is discussed. The model purposes that physiological, affective, and behavioral components of psychological traumatization maintain and exacerbate symptoms of pain and, similarly, that cognitive, affective and behavioral components of chronic musculoskeletal pain maintain or exacerbate symptoms of posttraumatic stress disorder. Some of these factors are expected to constitute a shared vulnerability [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B17">17</xref>]. The model of mutual maintenance was partially confirmed in a prospective study by Jenewein et al. They reported a mutual maintenance of posttraumatic stress symptoms and pain intensity within the first six months, but, at 12-month follow-up pain intensity was significantly influenced by posttraumatic stress symptom, whereas such symptoms of traumatization were no longer influenced by pain intensity [<xref ref-type="bibr" rid="B18">18</xref>].</p><p>Concerning treatment of CBP [<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B24">24</xref>] or psychological trauma [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B28">28</xref>] there are many guidelines. In spite of the high comorbidity of psychological trauma and pain, none of the guidelines for neither chronic pain nor psychological trauma incorporates the other, except the Expert Consensus Guideline Series for treatment of posttraumatic stress disorder [<xref ref-type="bibr" rid="B29">29</xref>]. Surprisingly, this guideline considers comorbid chronic pain only in the section of medical treatment.</p><p>Getting back to the before mentioned specific mechanism-based treatment approach, even if trauma-focused psychotherapy has been shown to be effective in the treatment of psychological trauma, the efficacy of trauma-focused psychotherapy in patients with chronic pain and previous psychological trauma as well as the underlying mechanisms have not yet been investigated in depth so far. However, there are some hints that this might be a promising approach [<xref ref-type="bibr" rid="B30">30</xref>-<xref ref-type="bibr" rid="B33">33</xref>]. The same is true for treatment of pain. It is not known whether such common treatment approaches are effective in patients with comorbid psychological trauma. This is important because research shows that patients with anxiety disorders and high comorbid pain interference have a lower likelihood of responding to treatment than patients without pain interference [<xref ref-type="bibr" rid="B34">34</xref>]. Therefore, research in regard to treatment of chronic pain with comorbid psychological trauma is necessary. Moreover, recent studies indicate that trauma-focused treatment approaches can successfully reduce comorbid symptoms also in non-posttraumatic stress symptomatology in which trauma is judged to be of causative significance [<xref ref-type="bibr" rid="B35">35</xref>].</p><p>A psychological first line treatment for psychological trauma, that has been proven to be efficacious, is eye movement desensitization and reprocessing (EMDR) [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B38">38</xref>]. Although EMDR was originally developed for individuals who had experienced psychological trauma, the neurobiological similarities found in patients who suffer from posttraumatic stress symptoms and chronic pain disorders encouraged scientists to explore the utilization of EMDR in the treatment of chronic pain, even in the absence of psychological trauma. Accordingly, there is an increasing amount of literature regarding the use of EMDR in the treatment of chronic pain.</p><p>Several studies report that EMDR is able to reduce pain intensity or even eliminate pain completely in patients with different pain disorders (e.g., phantom limb pain, fibromyalgia, and headache) [<xref ref-type="bibr" rid="B39">39</xref>]. Furthermore, EMDR has been found to improve pain coping abilities and to facilitate relaxation abilities that finally results in the reduction of pain and pain-related attitudes and beliefs [<xref ref-type="bibr" rid="B40">40</xref>].</p><p>However, until now there have predominantly been case-reports and case-series and none of them focused on CBP. Moreover, though there is first evidence that EMDR is effective and useful for the treatment of chronic pain, the underlying mechanisms still remain unclear.</p><p>Accordingly, we designed a randomized controlled trial on change in pain intensity by EMDR-treatment in patients suffering from chronic non-specific back pain and previous psychological trauma. In addition, our core study is expanded by a comprehensive neurobiological and psychosocial assessment to explore potential underlying mechanisms.</p><p>Therefore, the purpose of the present study is twofold: </p><p>1.) To determine whether a 10-session standardized EMDR short-term intervention in addition to treatment as usual (TAU) reduces pain intensity in CBP patients with experienced psychological trauma vs. TAU alone, and</p><p>2.) to explore additionally potential underlying mechanisms.</p></sec><sec><title>Methods and design</title><p>This study is part of the consortium &#x02018;Localized and Generalized Musculoskeletal Pain: Psychobiological Mechanisms and Implications for Treatment&#x02019; [<xref ref-type="bibr" rid="B41">41</xref>] funded by the German Federal Ministry of Research and Education (01EC1010A-F). More details concerning LOGIN can be found elsewhere [<xref ref-type="bibr" rid="B41">41</xref>-<xref ref-type="bibr" rid="B43">43</xref>]. This report is part of subproject number six (SP6; 01EC1010A) &#x02018;Subgroups Characterised by Psychological Trauma, Mental Co-morbidity, and Psychobiological Patterns and Their Specialised Treatment&#x02019; [<xref ref-type="bibr" rid="B43">43</xref>]. This trial has received ethics approval from the Ethics Committee Heidelberg (approval No. S-261/2010), and is registered within clinical trails.gov (NCT01850875). All participants must provide written informed consent.</p><sec><title>Design</title><p>The study is designed as a randomized controlled trial with two parallel arms (see Figure&#x000a0;<xref ref-type="fig" rid="F1">1</xref>). Forty patients will be randomized to either the treatment group (n&#x02009;=&#x02009;20) or the control group (n&#x02009;=&#x02009;20). The treatment group will receive EMDR in addition to TAU. The control group will receive TAU alone.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Intervention scheme.</bold> Outcome assessments will be done before randomization (T<sub>0</sub>, baseline), two weeks after intervention/treatment as usual (T<sub>1</sub>, primary endpoint), and six months after intervention/treatment as usual (T<sub>2</sub>, follow-up). CBP: non-specific chronic back pain.</p></caption><graphic xlink:href="1471-2474-14-256-1"/></fig></sec><sec><title>Participants</title><p>Participants will be recruited from the southwestern district &#x0201c;Rhein-Neckar&#x0201d; of Germany, through subproject six [<xref ref-type="bibr" rid="B43">43</xref>] of the LOGIN consortium. Patients will be offered enrolment, when in addition to CBP they additionally fulfill the criteria for experienced psychological trauma (see Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>). Recruitment will be done consecutively until a sample size of n&#x02009;=&#x02009;40 patients is reached (control group: n&#x02009;=&#x02009;20; intervention group: n&#x02009;=&#x02009;20). Randomization will be done centrally with the established randomization program RANDI<sub>2</sub>[<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>] after patient inclusion by an independent person not involved in treatment or assessment. Allocation concealment will be ensured, as this person will not release the randomization code until the patient has been recruited into the trial, which takes place after all baseline assessments have been completed.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Inclusion and exclusion criteria</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th colspan="2" align="left"><bold>Inclusion criteria</bold></th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="left" valign="bottom"><bold>Diagnosis</bold><hr/></td><td align="left" valign="bottom">1.) Non-specific CBP&#x02009;&#x02265;&#x02009;45&#x000a0;days during the past three months, and<hr/></td></tr><tr><td align="left" valign="bottom">2.) History of experienced psychological trauma*<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Age</bold><hr/></td><td align="left" valign="bottom">At least 18&#x000a0;years of age<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Language</bold><hr/></td><td align="left" valign="bottom">Fluent German language skills<hr/></td></tr><tr><td colspan="2" align="left" valign="bottom"><bold>Exclusion criteria</bold><hr/></td></tr><tr><td rowspan="4" align="left" valign="bottom"><bold>Pathology</bold><hr/></td><td align="left" valign="bottom">- Specific pathologies of CBP (e.g., spinal canal stenosis, disc hernia, spondylolisthesis, infection, malignancy, Bechterew disease, and fracture)<hr/></td></tr><tr><td align="left" valign="bottom">- Sciatica pain&#x02009;&#x02265;&#x02009;than back pain<hr/></td></tr><tr><td align="left" valign="bottom">- Severe physical or psychiatric co-morbidity<hr/></td></tr><tr><td align="left" valign="bottom">- Cognitive impairment<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Pension status</bold><hr/></td><td align="left" valign="bottom">Active or planned worker&#x02019;s compensation, disability or personal injury claims<hr/></td></tr><tr><td align="left"><bold>Medical status</bold></td><td align="left">Planned other or ongoing psychotherapy, change in medication in the last three months</td></tr></tbody></table><table-wrap-foot><p><italic>*Psychological trauma will be assessed using the German Version of the Posttraumatic Diagnostic Scale (PDS-D)</italic>[<xref ref-type="bibr" rid="B46">46</xref>]<italic>. Patients who at least answer one trauma item positive will be classified as patients with experienced psychological trauma. All other patients will be classified as patients without psychological trauma. For details see</italic>[<xref ref-type="bibr" rid="B43">43</xref>]<italic>.</italic></p></table-wrap-foot></table-wrap><p>Outcome assessments will be conducted by an assessor blind to treatment allocation. An employee outside the research team will feed data into the computer in separate datasheets so that the researchers can analyze data without having access to information about the allocation.</p></sec><sec><title>Inclusion and exclusion criteria</title><p>Diagnosis of non-specific chronic back pain and psychological trauma is validated within LOGIN subproject six. For details see [<xref ref-type="bibr" rid="B43">43</xref>]. Briefly, patients must report more than 44&#x000a0;days of low back pain within at least the last three months (=CBP). Then, to verify inclusion and exclusion criteria (Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>), all participants will be questioned about their past medical history and about co-morbidities. In addition, patients will also receive a physical examination (including blood tests and if indicated further technical investigations such as x-ray or MRI) that attaches special importance to findings which indicate a specific origin of back pain. Therefore the &#x0201c;red flags&#x0201d; (hints for the presence of serious pathology according to the Agency for Health Care Policy and Research Low Back Guidelines [<xref ref-type="bibr" rid="B47">47</xref>]) will be considered and former medical reports and discharge letters will be taken into account whenever available. In case of signs for serious pathological findings, participants will be excluded and a further investigation will be advised.</p><p>Psychological trauma will be diagnosed with the German Version of the Posttraumatic Distress Scale (PDS-D) [<xref ref-type="bibr" rid="B46">46</xref>]. Patients who at least answer one trauma item positive will be classified as patients with experienced psychological trauma. All other patients will be classified as patients without psychological trauma. For details see [<xref ref-type="bibr" rid="B43">43</xref>].</p><p>Participants that meet all the inclusion criteria will have the trial explained to them in detail and then be asked to provide written informed consent before being enrolled into the trial.</p></sec><sec><title>Description of intervention</title><p>All the participants will continue to receive their usual routine care (e.g., general support and advice, physiotherapy, simple analgesics for their symptoms) from their own general practitioners and other healthcare providers in accordance with the guidelines for the treatment of CBP in Germany [<xref ref-type="bibr" rid="B19">19</xref>].</p><p>In addition to TAU, the participants assigned to the EMDR intervention group will receive a manualized outpatient intervention that is based on the principles of EMDR-trauma therapy [<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>] and incorporates standardized EMDR pain protocols [<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B51">51</xref>]. The participants will receive ten 90-minute sessions in an individual setting. The intervention manual will be prepared in cooperation with an expert in trauma therapy. The EMDR treatment will be provided by EMDR-trained psychologists and physicians (who have participated in an EMDRIA-approved Basic Training program). The therapists will be trained in advance specifically in the use of EMDR for chronic pain patients and will be supervised regularly by an EMDRIA-approved consultant. All the sessions will be video-recorded. The therapists&#x02019; treatment fidelity will be managed by using standardized treatment protocols and regular supervision, including monitoring the video-recorded sessions.</p><p>Based on the theoretical rationale proposed by Carlson and colleagues [<xref ref-type="bibr" rid="B52">52</xref>] and the general recommendations for evaluating empirical EMDR studies [<xref ref-type="bibr" rid="B53">53</xref>], a &#x02018;dose&#x02019; of ten 90-minute sessions given over a 20-week period was chosen to guarantee sufficient treatment length. Although there is currently no definitive agreement on the number of EMDR treatment sessions required [<xref ref-type="bibr" rid="B48">48</xref>] and the existent literature suggests that EMDR is effective with fewer than ten sessions (e.g., van Rood 2009 [<xref ref-type="bibr" rid="B54">54</xref>]), we postulate that this number of treatment sessions will allow adequate time for testing comparative treatments as well.</p><p>Based on the theoretical rationale proposed by Carlson and colleagues [<xref ref-type="bibr" rid="B52">52</xref>], and the general recommendations for the evaluation of empirical EMDR studies [<xref ref-type="bibr" rid="B53">53</xref>] a &#x02018;dose&#x02019; of ten sessions &#x000e0; 90&#x000a0;minutes per session given over a 20-weeks period is chosen to guarantee sufficient treatment length. Even though there is currently no definitive agreement on the number of EMDR treatment sessions required [<xref ref-type="bibr" rid="B48">48</xref>], and existent literature supports EMDR effectiveness in fewer than ten sessions (e.g., van Rood 2009 [<xref ref-type="bibr" rid="B54">54</xref>]), we postulate that this number of treatment sessions would allow adequate time to test comparative treatments as well.</p></sec><sec><title>Data acquisition</title><p>All the outcome assessments and the EMDR sessions will be conducted at the Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Germany. The outcome assessments will be performed by an independent evaluator who is blinded to the treatment allocation at three time points: baseline (T<sub>0</sub>, before randomization), two weeks after the intervention/TAU (T<sub>1</sub>, primary endpoint), and six months after the intervention/TAU (T<sub>2</sub>, follow-up). The physical examination and the clinical interviews will only be conducted at baseline. The assessor will be trained at the beginning of the study and will be observed regularly to ensure the reliability and validity of the measures.</p></sec><sec><title>Outcome measures</title><p>The primary endpoint with respect to the efficacy of the standardized short-term EMDR intervention for CBP is the change in the intensity of back pain from T<sub>0</sub> to T<sub>1</sub> measured on a numeric rating scale (NRS 0&#x02013;10, averaged over four weeks). The NRS for pain intensity has proven to be a reliable and valid instrument for assessing treatment effects in pain trials [<xref ref-type="bibr" rid="B55">55</xref>].</p><p>The secondary outcomes, which include distinct pain variables (mean pain duration, pain experience, and pain intensity at T<sub>2</sub>), medication intake, health-related quality of life (SF-12), anxiety and depression (HADS), dissociation symptoms (FDS-20), psychological resilience (RS-11), and somatization (SCL-90R subscale somatization), will be measured at all assessment points (T<sub>1</sub> and T<sub>2</sub>).</p><p>In addition to the efficacy endpoints, we assess the peripheral and central modulation of pain (quantitative sensory testing, QST, and conditioned pain modulation, CPM) in all the patients to explore the differences in pain processing induced by the EMDR intervention. An overview of the primary and secondary outcomes is shown in Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Outcome measures</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/></colgroup><thead valign="top"><tr><th colspan="2" align="left"><bold>Primary outcome</bold></th></tr></thead><tbody valign="top"><tr><td align="left" valign="bottom"><bold>Pain intensity</bold><hr/></td><td align="left" valign="bottom">&#x02022; <italic>Numerical rating scale (NRS)</italic>, ranging from 0 &#x02018;no pain&#x02019; to 10 &#x02018;worst pain imaginable&#x02019; [<xref ref-type="bibr" rid="B55">55</xref>].<hr/></td></tr><tr><td colspan="2" align="left" valign="bottom"><bold>Secondary outcomes</bold><hr/></td></tr><tr><td rowspan="2" align="left" valign="bottom"><bold>Pain dimensions</bold><hr/></td><td align="left" valign="bottom">&#x02022; <italic>Pain duration</italic> (number of painful days in the last 4&#x000a0;weeks).<hr/></td></tr><tr><td align="left" valign="bottom">&#x02022; <italic>Pain Experience Scale (SES)</italic> measures the affective and sensory dimensions of pain [<xref ref-type="bibr" rid="B56">56</xref>].<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Medication</bold><hr/></td><td align="left" valign="bottom">&#x02022; Change in medication intake.<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Disability</bold><hr/></td><td align="left" valign="bottom">&#x02022; <italic>12-Item Short Form Health Survey (SF-12)</italic> measures health-related quality of life [<xref ref-type="bibr" rid="B57">57</xref>,<xref ref-type="bibr" rid="B58">58</xref>].<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Depression and Anxiety</bold><hr/></td><td align="left" valign="bottom">&#x02022; <italic>Hospital Anxiety and Depression Scale (HADS-D)</italic>[<xref ref-type="bibr" rid="B59">59</xref>].<hr/></td></tr><tr><td rowspan="2" align="left" valign="bottom"><bold>Stress/ Trauma</bold><hr/></td><td align="left" valign="bottom">&#x02022; <italic>Change in Posttraumatic Diagnostic Scale levels (PDS)</italic>[<xref ref-type="bibr" rid="B60">60</xref>]<italic>.</italic><hr/></td></tr><tr><td align="left" valign="bottom">&#x02022; <italic>Dissociation symptoms questionnaire (DES/FDS-20)</italic> for assessment of dissociative symptoms [<xref ref-type="bibr" rid="B61">61</xref>].<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Somatization</bold><hr/></td><td align="left" valign="bottom">&#x02022; <italic>Somatization scores</italic> of the SCL-90R subscale somatization (SCL-90R) [<xref ref-type="bibr" rid="B62">62</xref>].<hr/></td></tr><tr><td align="left" valign="bottom"><bold>Somato-sensory function</bold><hr/></td><td align="left" valign="bottom">&#x02022; <italic>Quantitative Sensory Testing (QST)</italic> for assessment of all relevant aspects of the somatosensory system including large and small fiber function as well as signs of central sensitization (dynamic tactile allodynia, punctate mechanical hyperalgesia) [<xref ref-type="bibr" rid="B63">63</xref>].<hr/></td></tr><tr><td align="left"><bold>Conditioned pain modulation</bold></td><td align="left"><italic>&#x02022; Conditioned Pain Modulation (CPM)</italic> paradigm for assessment of inhibitory pain modulating mechanisms [<xref ref-type="bibr" rid="B64">64</xref>]. Difference in pressure pain threshold before and after inducing CPM by a phasic heat pain stimulus will be measured.</td></tr></tbody></table></table-wrap><p>Moreover, as part of the LOGIN study, all the participants in our study will be assessed for a shared core set of variables, including a comprehensive assessment of neuromodulators (plasma nerve-growth-factor, plasma endocannabinoid and lipid levels) and the functional and structural changes in functional neuroimaging (fMRI), before and after treatment (for further details, see [<xref ref-type="bibr" rid="B43">43</xref>]).</p></sec><sec><title>Assessment of safety</title><p>Serious adverse events (SAEs) will be documented and reported casuistically.</p></sec><sec><title>Sample size estimation</title><p>The sample size calculation is based on the primary efficacy endpoint: change in the pain intensity (numeric rating scale 0&#x02013;10) after the intervention (T<sub>1</sub>). The expected effect size for our trial is derived from previous evidence about the effect of EMDR therapy for chronic pain patients.</p><p>The two controlled trials currently available are characterized by high effect sizes with Hedges&#x02019; g ranging from &#x02212;1.12 [<xref ref-type="bibr" rid="B65">65</xref>] to &#x02212;6.87 [<xref ref-type="bibr" rid="B66">66</xref>]. Based on this data, an effect size of at least 1.0 can be expected after ten sessions of treatment. A sample size of 17 patients in each group will have 80% power to detect an effect size of 1.0 using a t-test for independent groups with a 0.05 two-sided significance level. Based on comparable studies and our own experience with pain trials, we expect a 20% drop-out rate. Therefore, a total sample size of 40 patients is required for the study. The patients who are lost to follow up and/or non-compliant patients will be handled using an intention-to-treat procedure.</p></sec><sec><title>Statistical analyses</title><p>The data analysis will follow the evaluation standards for experimental study designs with control groups, using descriptive methods as well as inferential statistics. The data will be analyzed using an intention-to-treat approach. Because of the small sample size in the study, multiple imputation (the gold standard for handling missing values) is not appropriate. Therefore, only complete cases will be used in the final analysis. Dropouts, withdrawals and missing values will be analyzed in detail; different techniques will be used to assess them, and these techniques will be compared using sensitivity analyses. Descriptive statistics will be presented as the means and standard deviations for the continuous variables and absolute numbers and percentages for the categorical variables. The questionnaires will be processed in accordance with questionnaire manuals.</p><p>The differences between the change scores of the patient groups will be analyzed using independent t-tests. Moreover, potential negative effects will be reported descriptively (e.g., pain intensity after the trauma-focused intervention&#x02009;&#x0003e;&#x02009;pain intensity before the trauma focused intervention). Preliminary effect sizes will be estimated using Cohen&#x02019;s d.</p><p>Pre-processing analyses and statistical analyses of quantitative sensory testing data will be performed according to the protocol used by Rolke et al. [<xref ref-type="bibr" rid="B63">63</xref>]. To quantify conditioned pain modulation, the pressure pain threshold before a phasic heat stimulus will be subtracted from the pressure pain threshold after the phasic heat stimulus. A negative value indicates an analgesic effect due to CPM [<xref ref-type="bibr" rid="B64">64</xref>].</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Although CBP is often accompanied by psychological trauma and posttraumatic stress symptoms, a specific trauma-focused approach for this subgroup of CBP cases has been a neglected issue to date. Eye movement desensitization and reprocessing, originally developed as a short-duration, high-efficiency treatment approach for posttraumatic stress symptoms, is a promising approach for treating CBP in patients who have experienced psychological trauma. The preliminary evidence suggests that EMDR treatment may benefit patients with medically unexplained somatic symptoms [<xref ref-type="bibr" rid="B54">54</xref>]. To date, several uncontrolled studies using EMDR have been conducted for a multitude of various pain syndromes [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B66">66</xref>-<xref ref-type="bibr" rid="B70">70</xref>]. These studies suggest that EMDR may be a safe and promising treatment option for chronic pain conditions.</p><p>However, most of the research conducted thus far has been preliminary in nature and characterized by small sample sizes, heterogeneous patient groups, the lack of randomization and the absence of adequate control groups. Moreover, to our knowledge, none of these studies have evaluated the efficacy of EMDR in patients suffering CBP. Thus, there is an urgent need for further exploration of the efficacy of EMDR for treating chronic pain patients using well-designed studies with standardized EMDR interventions of sufficient treatment length and adequate control groups. Accordingly, we designed this randomized controlled trial on the effects of EMDR treatment for non-specific chronic back pain patients who have experienced psychological trauma to determine whether a standardized short-term EMDR intervention reduces pain intensity in this subgroup of CBP patients. Because this is the first randomized controlled trial on this topic, the results of this study will encourage a more specific trauma-focused treatment approach, especially for the pain patients who have experienced psychological trauma.</p><p>However, although there is preliminary evidence that EMDR is effective and useful for the treatment of chronic pain, the underlying mechanisms remain unclear. Therefore, our core study will be supplemented by a comprehensive neurophysiologic and psychosocial assessment to explore these mechanisms of action.</p><p>Notably, the study is part of the LOGIN consortium study [<xref ref-type="bibr" rid="B41">41</xref>]. LOGIN comprises seven subprojects, including basic and applied research as well as preclinical and clinical projects utilizing a wide variety of research methods. As part of this consortium study, all the participants in our study will additionally be assessed for a shared core set of variables to investigate similar pathogenetic mechanisms. This approach enables us to expand our exploration of the underlying mechanisms by conducting a comprehensive assessment of systemic neuromodulators (plasma nerve-growth-factor, plasma endocannabinoid and lipid levels) and the functional and structural changes with functional neuroimaging (fMRI) before and after treatment and to explore the differences in pain processing induced by the EMDR intervention. This approach will be supported by the translational aspects of LOGIN. Thus, using the synergy of the different subprojects, the timely translation, implementation and dissemination of the results will be guaranteed.</p><p>The findings of this study might contribute to improvements in the treatment of patients suffering from CBP as well as to better understanding of the mechanisms of action underlying EMDR in chronic pain patients.</p></sec><sec><title>Competing interest</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors&#x02019; contributions</title><p>AG and JT have made substantial contributions to conception and design and have been involved in drafting the manuscript. MH and WE have made substantial contributions to conception and design and revised the manuscript critically for important intellectual content. SL, SJ, GHS were involved in data collection and revised the manuscript critically for important intellectual content. All authors read and approved the final version of the manuscript to be published.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2474/14/256/prepub">http://www.biomedcentral.com/1471-2474/14/256/prepub</ext-link></p></sec></body><back><sec><title>Acknowledgements</title><p>The project is part of the research Consortium LOGIN: &#x0201c;Localized and Generalized Musculoskeletal Pain: Psychobiological Mechanisms and Implications for Treatment&#x0201d; funded by the German Federal Ministry of Education and Research (BMBF, 01EC1010A-E). This study is supported by a research grant from the BMBF, project 01EC1010A.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Maetzel</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><article-title>The economic burden of low back pain: a review of studies published between 1996 and 2001</article-title><source>Best Pract Res Clin Rheumatol</source><year>2002</year><volume>16</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1053/berh.2001.0204</pub-id><pub-id pub-id-type="pmid">11987929</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Depont</surname><given-names>F</given-names></name><name><surname>Hunsche</surname><given-names>E</given-names></name><name><surname>Abouelfath</surname><given-names>A</given-names></name><name><surname>Diatta</surname><given-names>T</given-names></name><name><surname>Addra</surname><given-names>I</given-names></name><name><surname>Grelaud</surname><given-names>A</given-names></name><name><surname>Lagnaoui</surname><given-names>R</given-names></name><name><surname>Molimard</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>N</given-names></name><article-title>Medical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in France</article-title><source>Fundam Clin Pharmacol</source><year>2010</year><volume>24</volume><fpage>101</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1111/j.1472-8206.2009.00730.x</pub-id><pub-id pub-id-type="pmid">19678853</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Ricci</surname><given-names>JA</given-names></name><name><surname>Stewart</surname><given-names>WF</given-names></name><name><surname>Chee</surname><given-names>E</given-names></name><name><surname>Leotta</surname><given-names>C</given-names></name><name><surname>Foley</surname><given-names>K</given-names></name><name><surname>Hochberg</surname><given-names>MC</given-names></name><article-title>Back pain exacerbations and lost productive time costs in United States workers</article-title><source>Spine</source><year>2006</year><volume>31</volume><fpage>3052</fpage><lpage>3060</lpage><pub-id pub-id-type="doi">10.1097/01.brs.0000249521.61813.aa</pub-id><pub-id pub-id-type="pmid">17173003</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Freburger</surname><given-names>JK</given-names></name><name><surname>Holmes</surname><given-names>GM</given-names></name><name><surname>Agans</surname><given-names>RP</given-names></name><name><surname>Jackman</surname><given-names>AM</given-names></name><name><surname>Darter</surname><given-names>JD</given-names></name><name><surname>Wallace</surname><given-names>AS</given-names></name><name><surname>Castel</surname><given-names>LD</given-names></name><name><surname>Kalsbeek</surname><given-names>WD</given-names></name><name><surname>Carey</surname><given-names>TS</given-names></name><article-title>The rising prevalence of chronic low back pain</article-title><source>Arch Intern Med</source><year>2009</year><volume>169</volume><fpage>251</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1001/archinternmed.2008.543</pub-id><pub-id pub-id-type="pmid">19204216</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Harkness</surname><given-names>EF</given-names></name><name><surname>Macfarlane</surname><given-names>GJ</given-names></name><name><surname>Silman</surname><given-names>AJ</given-names></name><name><surname>McBeth</surname><given-names>J</given-names></name><article-title>Is musculoskeletal pain more common now than 40 years ago?: Two population-based cross-sectional studies</article-title><source>Rheumatology</source><year>2005</year><volume>44</volume><fpage>890</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/keh599</pub-id><pub-id pub-id-type="pmid">15784630</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Ekman</surname><given-names>M</given-names></name><name><surname>J&#x000f6;nhagen</surname><given-names>S</given-names></name><name><surname>Hunsche</surname><given-names>E</given-names></name><name><surname>J&#x000f6;nsson</surname><given-names>L</given-names></name><article-title>Burden of illness of chronic low back pain in sweden: a cross-sectional, retrospective study in primary care setting</article-title><source>Spine</source><year>2005</year><volume>30</volume><fpage>1777</fpage><lpage>1785</lpage><pub-id pub-id-type="doi">10.1097/01.brs.0000171911.99348.90</pub-id><pub-id pub-id-type="pmid">16094281</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Gerhardt</surname><given-names>A</given-names></name><name><surname>Hartmann</surname><given-names>M</given-names></name><name><surname>Schuller-Roma</surname><given-names>B</given-names></name><name><surname>Blumenstiel</surname><given-names>K</given-names></name><name><surname>Bieber</surname><given-names>C</given-names></name><name><surname>Eich</surname><given-names>W</given-names></name><name><surname>Steffen</surname><given-names>S</given-names></name><article-title>The prevalence and type of Axis-I and Axis-II mental disorders in subjects with non-specific chronic back pain: results from a population-based study</article-title><source>Pain Med</source><year>2011</year><volume>12</volume><fpage>1231</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4637.2011.01190.x</pub-id><pub-id pub-id-type="pmid">21810166</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Sharp</surname><given-names>TJ</given-names></name><article-title>The prevalence of post-traumatic stress disorder in chronic pain patients</article-title><source>Curr Pain Headache Rep</source><year>2004</year><volume>8</volume><fpage>111</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1007/s11916-004-0024-x</pub-id><pub-id pub-id-type="pmid">14980145</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Asmundson</surname><given-names>GJG</given-names></name><name><surname>Coons</surname><given-names>MJ</given-names></name><name><surname>Taylor</surname><given-names>S</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name><article-title>PTSD and the experience of pain: research and clinical implications of shared vulnerability and mutual maintenance models</article-title><source>Can J Psychiatry</source><year>2002</year><volume>47</volume><fpage>930</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">12553128</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Anderberg</surname><given-names>UM</given-names></name><name><surname>Marteinsdottir</surname><given-names>I</given-names></name><name><surname>Theorell</surname><given-names>T</given-names></name><name><surname>von Knorring</surname><given-names>L</given-names></name><article-title>The impact of life events in female patients with fibromyalgia and in female healthy controls</article-title><source>Eur Psychiatry</source><year>2000</year><volume>15</volume><fpage>295</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.1016/S0924-9338(00)00397-7</pub-id><pub-id pub-id-type="pmid">10954873</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>H&#x000e4;user</surname><given-names>W</given-names></name><name><surname>Kosseva</surname><given-names>M</given-names></name><name><surname>&#x000dc;ceyler</surname><given-names>N</given-names></name><name><surname>Klose</surname><given-names>P</given-names></name><name><surname>Sommer</surname><given-names>C</given-names></name><article-title>Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis</article-title><source>Arthritis Care Res</source><year>2011</year><volume>63</volume><fpage>808</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1002/acr.20328</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Hauffa</surname><given-names>R</given-names></name><name><surname>Rief</surname><given-names>W</given-names></name><name><surname>Br&#x000e4;hler</surname><given-names>E</given-names></name><name><surname>Martin</surname><given-names>A</given-names></name><name><surname>Mewes</surname><given-names>R</given-names></name><name><surname>Glaesmer</surname><given-names>H</given-names></name><article-title>Lifetime traumatic experiences and posttraumatic stress disorder in the german population: results of a representative population survey</article-title><source>J Nerv Ment Dis</source><year>2011</year><volume>199</volume><fpage>934</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1097/NMD.0b013e3182392c0d</pub-id><pub-id pub-id-type="pmid">22134451</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Sledjeski</surname><given-names>EM</given-names></name><name><surname>Speisman</surname><given-names>B</given-names></name><name><surname>Dierker</surname><given-names>LC</given-names></name><article-title>Does number of lifetime traumas explain the relationship between PTSD and chronic medical conditions? Answers from the National Comorbidity Survey-Replication (NCS-R)</article-title><source>J Behav Med</source><year>2008</year><volume>31</volume><fpage>341</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1007/s10865-008-9158-3</pub-id><pub-id pub-id-type="pmid">18553129</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Young Casey</surname><given-names>C</given-names></name><name><surname>Greenberg</surname><given-names>MA</given-names></name><name><surname>Nicassio</surname><given-names>PM</given-names></name><name><surname>Harpin</surname><given-names>RE</given-names></name><name><surname>Hubbard</surname><given-names>D</given-names></name><article-title>Transition from acute to chronic pain and disability: a model including cognitive, affective, and trauma factors</article-title><source>Pain</source><year>2008</year><volume>134</volume><fpage>69</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2007.03.032</pub-id><pub-id pub-id-type="pmid">17504729</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>EA</given-names></name><name><surname>McBeth</surname><given-names>J</given-names></name><name><surname>Nicholl</surname><given-names>B</given-names></name><name><surname>Morriss</surname><given-names>RK</given-names></name><name><surname>Dickens</surname><given-names>C</given-names></name><name><surname>Jones</surname><given-names>GT</given-names></name><name><surname>Macfarlane</surname><given-names>GJ</given-names></name><article-title>What characterizes persons who do not report musculoskeletal pain? Results from a 4-year population-based longitudinal study (The Epifund Study)</article-title><source>J Rheumatol</source><year>2009</year><volume>36</volume><fpage>1071</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.3899/jrheum.080541</pub-id><pub-id pub-id-type="pmid">19369469</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Asmundson</surname><given-names>GJG</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name><article-title>Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art</article-title><source>Depress Anxiety</source><year>2009</year><volume>26</volume><fpage>888</fpage><lpage>901</lpage><pub-id pub-id-type="doi">10.1002/da.20600</pub-id><pub-id pub-id-type="pmid">19691031</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Sharp</surname><given-names>TJ</given-names></name><name><surname>Harvey</surname><given-names>AG</given-names></name><article-title>Chronic pain and posttraumatic stress disorder: mutual maintenance?</article-title><source>Clin Psychol Rev</source><year>2001</year><volume>21</volume><fpage>857</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1016/S0272-7358(00)00071-4</pub-id><pub-id pub-id-type="pmid">11497210</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Jenewein</surname><given-names>J</given-names></name><name><surname>Wittmann</surname><given-names>L</given-names></name><name><surname>Moergeli</surname><given-names>H</given-names></name><name><surname>Creutzig</surname><given-names>J</given-names></name><name><surname>Schnyder</surname><given-names>U</given-names></name><article-title>Mutual influence of posttraumatic stress disorder symptoms and chronic pain among injured accident survivors: a longitudinal study</article-title><source>J Trauma Stress</source><year>2009</year><volume>22</volume><fpage>540</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">19924822</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="other"><collab>Association of the Scientific Medical Societies in Germany (AWMF)</collab><source>National guideline for low back pain &#x02013; long version</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.versorgungsleitlinien.de/themen/kreuzschmerz">http://www.versorgungsleitlinien.de/themen/kreuzschmerz</ext-link></comment><pub-id pub-id-type="pmid">23230403</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Bach</surname><given-names>SM</given-names></name><name><surname>Holten</surname><given-names>KB</given-names></name><article-title>Guideline update: what&#x02019;s the best approach to acute low back pain?</article-title><source>J Fam Pract</source><year>2009</year><volume>58</volume><fpage>E1</fpage><pub-id pub-id-type="pmid">19961812</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="book"><name><surname>Becker</surname><given-names>A</given-names></name><name><surname>Chenot</surname><given-names>JF</given-names></name><name><surname>Niebling</surname><given-names>W</given-names></name><name><surname>Kochen</surname><given-names>MM</given-names></name><source>DEGAM guideline low back pain</source><year>2003</year><publisher-name>D&#x000fc;sseldorf: Omikron Publishing</publisher-name></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="book"><collab>Royal College of General Practitioners</collab><source>Clinical guidelines for the management of acute low back pain</source><year>1999</year><publisher-name>London: Royal College of General Practitioners</publisher-name></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Airaksinen</surname><given-names>O</given-names></name><name><surname>Brox</surname><given-names>JI</given-names></name><name><surname>Cedraschi</surname><given-names>C</given-names></name><name><surname>Hildebrandt</surname><given-names>J</given-names></name><name><surname>Klaber-Moffett</surname><given-names>J</given-names></name><name><surname>Kovacs</surname><given-names>F</given-names></name><name><surname>Mannion</surname><given-names>AF</given-names></name><name><surname>Reis</surname><given-names>S</given-names></name><name><surname>Staal</surname><given-names>JB</given-names></name><name><surname>Ursin</surname><given-names>H</given-names></name><name><surname>Zanoli</surname><given-names>G</given-names></name><article-title>COST B13 working group on guidelines for chronic low back pain: chapter 4 European guidelines for the management of chronic nonspecific low back pain</article-title><source>Eur Spine J</source><year>2006</year><volume>15</volume><issue>Suppl 2</issue><fpage>192</fpage><lpage>300</lpage></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Dagenais</surname><given-names>S</given-names></name><name><surname>Tricco</surname><given-names>AC</given-names></name><name><surname>Haldeman</surname><given-names>S</given-names></name><article-title>Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines</article-title><source>Spine J</source><year>2010</year><volume>10</volume><fpage>514</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.spinee.2010.03.032</pub-id><pub-id pub-id-type="pmid">20494814</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Foa</surname><given-names>EB</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>Friedman</surname><given-names>MJ</given-names></name><article-title>Guidelines for treatment of PTSD</article-title><source>J Trauma Stress</source><year>2000</year><volume>13</volume><fpage>539</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1023/A:1007802031411</pub-id><pub-id pub-id-type="pmid">11109232</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="book"><name><surname>Foa</surname><given-names>EB</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>Friedman</surname><given-names>MJ</given-names></name><name><surname>Cohen</surname><given-names>JA</given-names></name><source>Effective treatments for PTSD: practice guidelines from the international society for traumatic stress studies</source><year>2009</year><edition>2</edition><publisher-name>New York: Guilford Press</publisher-name></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Bisson</surname><given-names>J</given-names></name><name><surname>Andrew</surname><given-names>M</given-names></name><article-title>Psychological treatment of post-traumatic stress disorder (PTSD)</article-title><source>Cochrane Database Syst Rev</source><year>2007</year><volume>18</volume><comment>CD003388</comment></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Flatten</surname><given-names>G</given-names></name><name><surname>Gast</surname><given-names>U</given-names></name><name><surname>Hofmann</surname><given-names>A</given-names></name><name><surname>Liebermann</surname><given-names>P</given-names></name><name><surname>Reddemann</surname><given-names>L</given-names></name><name><surname>Siol</surname><given-names>T</given-names></name><name><surname>W&#x000f6;ller</surname><given-names>W</given-names></name><name><surname>Petzold</surname><given-names>ER</given-names></name><article-title>S3-Leitlinie posttraumatische Belastungsst&#x000f6;rung</article-title><source>Trauma Gewalt</source><year>2011</year><volume>5</volume><fpage>202</fpage><lpage>210</lpage></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><article-title>The expert consensus guideline series: treatment of posttraumatic stress disorder. the expert consensus panels for PTSD (no authors listed)</article-title><source>J Clin Psychiatry</source><year>1999</year><volume>16</volume><issue>16</issue><fpage>3</fpage><lpage>76</lpage></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Dunne</surname><given-names>RL</given-names></name><name><surname>Kenardy</surname><given-names>J</given-names></name><name><surname>Sterling</surname><given-names>M</given-names></name><article-title>A randomized controlled trial of cognitive-behavioral therapy for the treatment of PTSD in the context of chronic whiplash</article-title><source>Clin J Pain</source><year>2012</year><volume>28</volume><fpage>755</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1097/AJP.0b013e318243e16b</pub-id><pub-id pub-id-type="pmid">22209798</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Liedl</surname><given-names>A</given-names></name><name><surname>Knaevelsrud</surname><given-names>C</given-names></name><article-title>PTBS und chronische Schmerzen: Entstehung, Aufrechterhaltung und Zusammenhang &#x02013; ein &#x000dc;berblick</article-title><source>Schmerz</source><year>2008</year><volume>22</volume><fpage>644</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1007/s00482-008-0714-0</pub-id><pub-id pub-id-type="pmid">18726123</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Otis</surname><given-names>JD</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>Kerns</surname><given-names>RD</given-names></name><article-title>An examination of the relationship between chronic pain and post-traumatic stress disorder</article-title><source>J Rehabil Res Dev</source><year>2003</year><volume>40</volume><fpage>397</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1682/JRRD.2003.09.0397</pub-id><pub-id pub-id-type="pmid">15080224</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Otis</surname><given-names>JD</given-names></name><name><surname>Keane</surname><given-names>TM</given-names></name><name><surname>Kerns</surname><given-names>RD</given-names></name><name><surname>Monson</surname><given-names>C</given-names></name><name><surname>Scioli</surname><given-names>E</given-names></name><article-title>The development of an integrated treatment for veterans with comorbid chronic pain and posttraumatic stress disorder</article-title><source>Pain Med</source><year>2009</year><volume>10</volume><fpage>1300</fpage><lpage>1311</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4637.2009.00715.x</pub-id><pub-id pub-id-type="pmid">19818040</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Teh</surname><given-names>CF</given-names></name><name><surname>Morone</surname><given-names>NE</given-names></name><name><surname>Karp</surname><given-names>JF</given-names></name><name><surname>Belnap</surname><given-names>BH</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Weiner</surname><given-names>DK</given-names></name><name><surname>Rollman</surname><given-names>BL</given-names></name><article-title>Pain interference impacts response to treatment for anxiety disorders</article-title><source>Depress Anxiety</source><year>2009</year><volume>26</volume><fpage>222</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1002/da.20514</pub-id><pub-id pub-id-type="pmid">19133701</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Laugharne</surname><given-names>J</given-names></name><name><surname>Lillee</surname><given-names>A</given-names></name><name><surname>Janca</surname><given-names>A</given-names></name><article-title>Role of psychological trauma in the cause and treatment of anxiety and depressive disorders</article-title><source>Curr Opin Psychiatry</source><year>2010</year><volume>23</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1097/YCO.0b013e3283345dc5</pub-id><pub-id pub-id-type="pmid">19901834</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Bisson</surname><given-names>J</given-names></name><name><surname>Andrew</surname><given-names>M</given-names></name><article-title>Psychological treatment of post-traumatic stress disorder (PTSD)</article-title><source>Cochrane Database Syst Rev</source><year>2005</year><volume>18</volume><comment>CD003388</comment></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Van Etten</surname><given-names>ML</given-names></name><name><surname>Taylor</surname><given-names>S</given-names></name><article-title>Comparative efficacy of treatments for post-traumatic stress disorder: a meta-analysis</article-title><source>Clin Psychol Psychother</source><year>1998</year><volume>5</volume><fpage>126</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1099-0879(199809)5:3&#x0003c;126::AID-CPP153&#x0003e;3.0.CO;2-H</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Seidler</surname><given-names>G</given-names></name><name><surname>Wagner</surname><given-names>F</given-names></name><article-title>Comparing the efficacy of EMDR and trauma-focused cognitive-behavioral therapy in the treatment of PTSD: a meta-analytic study</article-title><source>Psychol Med</source><year>2006</year><volume>36</volume><fpage>1515</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1017/S0033291706007963</pub-id><pub-id pub-id-type="pmid">16740177</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Gerhardt</surname><given-names>A</given-names></name><name><surname>Eich</surname><given-names>W</given-names></name><name><surname>Seidler</surname><given-names>G</given-names></name><name><surname>Tesarz</surname><given-names>J</given-names></name><article-title>Eye movement desensitization and reprocessing in chronic pain conditions</article-title><source>OA Musculoskeletal Medicine</source><year>2013</year><volume>1</volume><fpage>7</fpage></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Grant</surname><given-names>M</given-names></name><name><surname>Threlfo</surname><given-names>C</given-names></name><article-title>EMDR in the treatment of chronic pain</article-title><source>J Clin Psychol</source><year>2002</year><volume>58</volume><fpage>1505</fpage><lpage>1520</lpage><pub-id pub-id-type="doi">10.1002/jclp.10101</pub-id><pub-id pub-id-type="pmid">12455018</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="other"><source>LOGIN - Localized and generalized musculoskelettal pain: Psychobiological mechanisms and implications for treatment</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.login-verbund.de/index.php?id=2&#x00026;L=1">http://www.login-verbund.de/index.php?id=2&#x00026;L=1</ext-link></comment></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Viniol</surname><given-names>A</given-names></name><name><surname>Jegan</surname><given-names>N</given-names></name><name><surname>Leonhardt</surname><given-names>C</given-names></name><name><surname>Strauch</surname><given-names>K</given-names></name><name><surname>Brugger</surname><given-names>M</given-names></name><name><surname>Barth</surname><given-names>J</given-names></name><name><surname>Baum</surname><given-names>E</given-names></name><name><surname>Becker</surname><given-names>A</given-names></name><article-title>Study protocol: transition from localized low back pain to chronic widespread pain in general practice: Identification of risk factors, preventive factors and key elements for treatment - a cohort study</article-title><source>BMC Musculoskelet Disord</source><year>2012</year><volume>13</volume><fpage>77</fpage><pub-id pub-id-type="doi">10.1186/1471-2474-13-77</pub-id><pub-id pub-id-type="pmid">22630134</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Gerhardt</surname><given-names>A</given-names></name><name><surname>Hartmann</surname><given-names>M</given-names></name><name><surname>Tesarz</surname><given-names>J</given-names></name><name><surname>Janke</surname><given-names>S</given-names></name><name><surname>Leisner</surname><given-names>S</given-names></name><name><surname>Seidler</surname><given-names>G</given-names></name><name><surname>Eich</surname><given-names>W</given-names></name><article-title>Subgroups of musculoskeletal pain patients and their psychobiological patterns - The LOGIN study protocol</article-title><source>BMC Musculoskelet Disord</source><year>2012</year><volume>13</volume><fpage>136</fpage><pub-id pub-id-type="doi">10.1186/1471-2474-13-136</pub-id><pub-id pub-id-type="pmid">22862787</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="other"><source>RANDI2 - An open source randomization solution</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.randi2.org">http://www.randi2.org</ext-link></comment></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Schrimpf</surname><given-names>D</given-names></name><name><surname>Plotnicki</surname><given-names>L</given-names></name><name><surname>Pilz</surname><given-names>LR</given-names></name><article-title>Web-based open source application for the randomization process in clinical trials: RANDI2</article-title><source>Int J Clin Pharmacol Ther</source><year>2010</year><volume>48</volume><fpage>465</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">20557846</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="book"><name><surname>Ehlers</surname><given-names>A</given-names></name><name><surname>Steil</surname><given-names>R</given-names></name><name><surname>Winter</surname><given-names>H</given-names></name><name><surname>Foa</surname><given-names>EB</given-names></name><source>Deutsche &#x000fc;bersetzung der posttraumatic diagnostic scale (PDS)</source><year>1996</year><publisher-name>Oxford: University, Warreford Hospital</publisher-name></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Rubinstein</surname><given-names>SM</given-names></name><name><surname>van Tulder</surname><given-names>M</given-names></name><article-title>A best-evidence review of diagnostic procedures for neck and low-back pain</article-title><source>Best Pract Res Clin Rheumatol</source><year>2008</year><volume>22</volume><fpage>471</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.berh.2007.12.003</pub-id><pub-id pub-id-type="pmid">18519100</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="book"><name><surname>Shapiro</surname><given-names>F</given-names></name><source>Eye Movement Desensitization and Reprocessing (EMDR): basic principles, protocols, and procedures</source><year>2001</year><edition>2</edition><publisher-name>New York: The Guilford Press</publisher-name></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Shapiro</surname><given-names>F</given-names></name><article-title>Eye movement desensitization: a new treatment for post-traumatic stress disorder</article-title><source>J Behav Ther Exp Psychiatry</source><year>1989</year><volume>20</volume><fpage>211</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/0005-7916(89)90025-6</pub-id><pub-id pub-id-type="pmid">2576656</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="book"><name><surname>De Roos</surname><given-names>C</given-names></name><name><surname>Veenstra</surname><given-names>AC</given-names></name><person-group person-group-type="editor">Luber M</person-group><article-title>EMDR pain protocol fur current pain</article-title><source>Eye Movement Desensitization and Reprocessing (EMDR): special populations</source><year>2009</year><publisher-name>New York: Springer</publisher-name><fpage>537</fpage><lpage>557</lpage></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="book"><name><surname>Grant</surname><given-names>M</given-names></name><source>Pain control with EMDR</source><year>1999</year><publisher-name>Denver: Mentor Books</publisher-name></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Carlson</surname><given-names>J</given-names></name><name><surname>Chemtob</surname><given-names>C</given-names></name><name><surname>Rusnak</surname><given-names>K</given-names></name><name><surname>Hedlund</surname><given-names>N</given-names></name><name><surname>Muraoka</surname><given-names>M</given-names></name><article-title>Eye movement desensitization and reprocessing (EMDR) treatment for combat-related posttraumatic stress disorder</article-title><source>J Trauma Stress</source><year>1998</year><volume>11</volume><fpage>3</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1023/A:1024448814268</pub-id><pub-id pub-id-type="pmid">9479673</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Hertlein</surname><given-names>KM</given-names></name><name><surname>Ricci</surname><given-names>RJ</given-names></name><article-title>A systematic research synthesis of EMDR studies: implementation of the platinum standard</article-title><source>Trauma Violence Abuse</source><year>2004</year><volume>5</volume><fpage>285</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1177/1524838004264340</pub-id><pub-id pub-id-type="pmid">15189638</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>van Rood</surname><given-names>YR</given-names></name><name><surname>de Roos</surname><given-names>C</given-names></name><article-title>EMDR in the treatment of medically unexplained symptoms: a systematic review</article-title><source>J EMDR Pract Res</source><year>2009</year><volume>3</volume><fpage>248</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1891/1933-3196.3.4.248</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Dworkin</surname><given-names>RH</given-names></name><name><surname>Turk</surname><given-names>DC</given-names></name><name><surname>Farrar</surname><given-names>JT</given-names></name><name><surname>Haythornthwaite</surname><given-names>JA</given-names></name><name><surname>Jensen</surname><given-names>MP</given-names></name><name><surname>Katz</surname><given-names>NP</given-names></name><name><surname>Kerns</surname><given-names>RD</given-names></name><name><surname>Stucki</surname><given-names>G</given-names></name><name><surname>Allen</surname><given-names>RR</given-names></name><name><surname>Bellamy</surname><given-names>N</given-names></name><name><surname>Carr</surname><given-names>DB</given-names></name><name><surname>Chandler</surname><given-names>J</given-names></name><name><surname>Cowan</surname><given-names>P</given-names></name><name><surname>Dionne</surname><given-names>R</given-names></name><name><surname>Galer</surname><given-names>BS</given-names></name><name><surname>Hertz</surname><given-names>S</given-names></name><name><surname>Jadad</surname><given-names>AR</given-names></name><name><surname>Kramer</surname><given-names>LD</given-names></name><name><surname>Manning</surname><given-names>DC</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>McCormick</surname><given-names>CG</given-names></name><name><surname>McDermott</surname><given-names>MP</given-names></name><name><surname>McGrath</surname><given-names>P</given-names></name><name><surname>Quessy</surname><given-names>S</given-names></name><name><surname>Rappaport</surname><given-names>BA</given-names></name><name><surname>Robbins</surname><given-names>W</given-names></name><name><surname>Robinson</surname><given-names>JP</given-names></name><name><surname>Rothman</surname><given-names>M</given-names></name><name><surname>Royal</surname><given-names>MA</given-names></name><name><surname>Simon</surname><given-names>L</given-names></name><etal/><article-title>IMMPACT: core outcome measures for chronic pain clinical trials: IMMPACT recommendations</article-title><source>Pain</source><year>2005</year><volume>113</volume><fpage>9</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2004.09.012</pub-id><pub-id pub-id-type="pmid">15621359</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="book"><name><surname>Geissner</surname><given-names>E</given-names></name><source>Die Schmerzempfindungs-Skala (SES): handanweisung</source><year>1996</year><publisher-name>G&#x000f6;ttingen: Hogrefe</publisher-name></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><name><surname>Ware</surname><given-names>JEJ</given-names></name><name><surname>Kosinski</surname><given-names>M</given-names></name><name><surname>Keller</surname><given-names>SD</given-names></name><article-title>A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity</article-title><source>Med Care</source><year>1996</year><volume>34</volume><fpage>220</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1097/00005650-199603000-00003</pub-id><pub-id pub-id-type="pmid">8628042</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="book"><name><surname>Bullinger</surname><given-names>M</given-names></name><name><surname>Kirchberger</surname><given-names>I</given-names></name><source>SF-36 Fragebogen zum gesundheitszustand: handanweisung</source><year>1998</year><publisher-name>G&#x000f6;ttingen: Hogrefe</publisher-name></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="book"><name><surname>Hermann</surname><given-names>C</given-names></name><name><surname>Buss</surname><given-names>U</given-names></name><name><surname>Snaith</surname><given-names>RP</given-names></name><source>Hospital anxiety and depression scale - deutsche version. ein fragebogen zur erfassung von angst und depressivit&#x000e4;t in der somatischen medizin</source><year>2011</year><publisher-name>Verlag Hans Huber: Bern</publisher-name></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><name><surname>Griesel</surname><given-names>D</given-names></name><name><surname>Wessa</surname><given-names>M</given-names></name><name><surname>Flor</surname><given-names>H</given-names></name><article-title>Psychometric qualities of the german version of the posttraumatic diagnostic scale (PDSD)</article-title><source>Psychol Assess</source><year>2006</year><volume>18</volume><fpage>262</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">16953729</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><name><surname>Rodewald</surname><given-names>F</given-names></name><name><surname>Gast</surname><given-names>U</given-names></name><name><surname>Emrich</surname><given-names>HM</given-names></name><article-title>Screening auf komplexe dissoziative st&#x000f6;rungen mit dem fragebogen f&#x000fc;r dissoziative symptome (FDS)</article-title><source>Psychother Psych Med</source><year>2006</year><volume>56</volume><fpage>249</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1055/s-2006-932590</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="book"><name><surname>Franke</surname><given-names>G</given-names></name><source>Die symptom-checkliste von derogatis &#x02013; deutsche version (SCL-90-R)</source><year>1995</year><publisher-name>G&#x000f6;ttingen: Beltz Test</publisher-name></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><name><surname>Rolke</surname><given-names>R</given-names></name><name><surname>Baron</surname><given-names>R</given-names></name><name><surname>Maier</surname><given-names>C</given-names></name><name><surname>T&#x000f6;lle</surname><given-names>TR</given-names></name><name><surname>Treede</surname><given-names>RD</given-names></name><name><surname>Beyer</surname><given-names>A</given-names></name><name><surname>Binder</surname><given-names>A</given-names></name><name><surname>Birbaumer</surname><given-names>N</given-names></name><name><surname>Birklein</surname><given-names>F</given-names></name><name><surname>B&#x000f6;tef&#x000fc;r</surname><given-names>IC</given-names></name><name><surname>Braune</surname><given-names>S</given-names></name><name><surname>Flor</surname><given-names>H</given-names></name><name><surname>Huge</surname><given-names>V</given-names></name><name><surname>Klug</surname><given-names>R</given-names></name><name><surname>Landwehrmeyer</surname><given-names>GB</given-names></name><name><surname>Magerl</surname><given-names>W</given-names></name><name><surname>Maih&#x000f6;fner</surname><given-names>C</given-names></name><name><surname>Rolko</surname><given-names>C</given-names></name><name><surname>Schaub</surname><given-names>C</given-names></name><name><surname>Scherens</surname><given-names>A</given-names></name><name><surname>Sprenger</surname><given-names>T</given-names></name><name><surname>Valet</surname><given-names>M</given-names></name><name><surname>Wasserka</surname><given-names>B</given-names></name><article-title>Quantitative sensory testing in the german research network on neuropathic Pain (DFNS): standardized protocol and reference values</article-title><source>Pain</source><year>2006</year><volume>123</volume><fpage>231</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2006.01.041</pub-id><pub-id pub-id-type="pmid">16697110</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><name><surname>Pud</surname><given-names>D</given-names></name><name><surname>Granovsky</surname><given-names>Y</given-names></name><name><surname>Yarnitsky</surname><given-names>D</given-names></name><article-title>The methodology of experimentally induced diffuse noxious inhibitory control (DNIC)-like effect in humans</article-title><source>Pain</source><year>2009</year><volume>144</volume><fpage>16</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2009.02.015</pub-id><pub-id pub-id-type="pmid">19359095</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="book"><name><surname>Estergard</surname><given-names>L</given-names></name><source>Eye movement desensitization and reprocessing in the treatment of chronic pain</source><year>2009</year><publisher-name>Walden: Walden University</publisher-name></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><name><surname>Marcus</surname><given-names>SV</given-names></name><article-title>Phase 1 of integrated EMDR - an abortive treatment for migraine headaches</article-title><source>J EMDR Pract Res</source><year>2008</year><volume>2</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1891/1933-3196.2.1.15</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><name><surname>Schneider</surname><given-names>J</given-names></name><name><surname>Hofmann</surname><given-names>A</given-names></name><name><surname>Rost</surname><given-names>C</given-names></name><name><surname>Shapiro</surname><given-names>F</given-names></name><article-title>EMDR in the treatment of chronic phantom limb pain</article-title><source>Pain Med</source><year>2008</year><volume>9</volume><fpage>76</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">18254770</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><name><surname>Wilensky</surname><given-names>M</given-names></name><article-title>Eye movement desensitization and reprocessing (EMDR) as a treatment for phantom limb pain</article-title><source>J Brief Ther</source><year>2006</year><volume>5</volume><fpage>31</fpage><lpage>44</lpage></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><name><surname>Mazzola</surname><given-names>A</given-names></name><name><surname>Calcagno</surname><given-names>M</given-names></name><name><surname>Luj&#x000e0;n</surname></name><name><surname>Goicochea</surname><given-names>M</given-names></name><name><surname>Teresa</surname></name><name><surname>Pueyrred&#x000f2;n</surname><given-names>H</given-names></name><name><surname>Leston</surname><given-names>J</given-names></name><name><surname>Salvat</surname><given-names>F</given-names></name><article-title>EMDR in the treatment of chronic pain</article-title><source>J EMDR Pract Res</source><year>2009</year><volume>3</volume><fpage>66</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1891/1933-3196.3.2.66</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><name><surname>Kavakc&#x00131;</surname><given-names>O</given-names></name><name><surname>Semiz</surname><given-names>M</given-names></name><name><surname>Kaptanoglu</surname><given-names>E</given-names></name><name><surname>Ozer</surname><given-names>Z</given-names></name><article-title>EMDR treatment in fibromyalgia, a study of seven cases</article-title><source>Anatolian J Psychiatry</source><year>2012</year><volume>13</volume><fpage>75</fpage><lpage>81</lpage></mixed-citation></ref></ref-list></back></article>